These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17100636)

  • 21. Regulation of antitumour immunity by CD1d-restricted NKT cells.
    Swann J; Crowe NY; Hayakawa Y; Godfrey DI; Smyth MJ
    Immunol Cell Biol; 2004 Jun; 82(3):323-31. PubMed ID: 15186264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases.
    Miyake S; Yamamura T
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):315-22. PubMed ID: 16178791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
    Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
    J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A molecular switch in mouse CD1d modulates natural killer T cell activation by α-galactosylsphingamides.
    Wang J; Guillaume J; Janssens J; Remesh SG; Ying G; Bitra A; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Sep; 294(39):14345-14356. PubMed ID: 31391251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
    Dasgupta S; Kumar V
    Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased STAT-1 phosphorylation by a thio analogue of beta-D-glucosylceramide is associated with altered NKT lymphocyte polarization.
    Ben Ya'acov A; Lalazar G; Livovsky DM; Kanovich D; Axelrod E; Preston S; Schwarzmann G; Ilan Y
    Mol Immunol; 2009 Dec; 47(2-3):526-33. PubMed ID: 19818503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells.
    Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P
    J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands.
    Tsuji M
    Cell Mol Life Sci; 2006 Aug; 63(16):1889-98. PubMed ID: 16794785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.
    Kjer-Nielsen L; Borg NA; Pellicci DG; Beddoe T; Kostenko L; Clements CS; Williamson NA; Smyth MJ; Besra GS; Reid HH; Bharadwaj M; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2006 Mar; 203(3):661-73. PubMed ID: 16505140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.
    Baron JL; Gardiner L; Nishimura S; Shinkai K; Locksley R; Ganem D
    Immunity; 2002 Apr; 16(4):583-94. PubMed ID: 11970881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
    Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors.
    Brigl M; van den Elzen P; Chen X; Meyers JH; Wu D; Wong CH; Reddington F; Illarianov PA; Besra GS; Brenner MB; Gumperz JE
    J Immunol; 2006 Mar; 176(6):3625-34. PubMed ID: 16517731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
    Zajonc DM; Kronenberg M
    Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni.
    Mallevaey T; Zanetta JP; Faveeuw C; Fontaine J; Maes E; Platt F; Capron M; de-Moraes ML; Trottein F
    J Immunol; 2006 Feb; 176(4):2476-85. PubMed ID: 16456008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.
    Shin JH; Park SH
    BMB Rep; 2014 May; 47(5):241-8. PubMed ID: 24755556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.